THOMAS MCNERNEY & PARTNERS LP

CIK 00012312915 companiesMINNEAPOLIS, MN

SEC Profile

Transactions

Companies

Filings

CIK

0001231291

Recent Transactions

50 trades

Sale
CLARUS THERAPEUTICS INC
Common Stock
2022-04-20$2.53/sh−1,164→ 542 total
Sale
CLARUS THERAPEUTICS INC
Common Stock
2022-04-20$2.53/sh−13,630→ 6,340 total
Sale
CLARUS THERAPEUTICS INC
Common Stock
2022-04-20$2.53/sh−7,585→ 3,528 total
Sale
Clarus Therapeutics Holdings, Inc.
Common Stock
2022-04-20$2.53/sh−2,061,685→ 958,989 total
Sale
Clarus Therapeutics Holdings, Inc.
Common Stock
2022-04-20$2.53/sh−5,722→ 2,661 total
Sale
Clarus Therapeutics Holdings, Inc.
Common Stock
2022-04-20$2.53/sh−1,164→ 542 total
Sale
Clarus Therapeutics Holdings, Inc.
Common Stock
2022-04-20$2.53/sh−7,585→ 3,528 total
Sale
Clarus Therapeutics Holdings, Inc.
Common Stock
2022-04-20$2.53/sh−1,663,126→ 773,599 total
Sale
Clarus Therapeutics Holdings, Inc.
Common Stock
2022-04-20$2.53/sh−13,630→ 6,340 total
Sale
CLARUS THERAPEUTICS INC
Common Stock
2022-04-20$2.53/sh−2,061,685→ 958,989 total
Sale
CLARUS THERAPEUTICS INC
Common Stock
2022-04-20$2.53/sh−5,722→ 2,661 total
Sale
CLARUS THERAPEUTICS INC
Common Stock
2022-04-20$2.53/sh−1,663,126→ 773,599 total
Other
Ocera Therapeutics, Inc.
Common Stock, par value $0.00001 per share
2013-07-15$6.00/sh+762,892→ 762,892 total
Other
Ocera Therapeutics, Inc.
Common Stock, par value $0.00001 per share
2013-07-15$6.00/sh+1,675,677→ 1,675,677 total
Award
Ocera Therapeutics, Inc.
Warrants
2012-10-01$44.23/sh+161,855→ 161,855 total
Award
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2012-08-07+31,835→ 31,835 total
Award
Ocera Therapeutics, Inc.
Warrants
2012-03-30$44.23/sh+161,855→ 161,855 total
Award
Ocera Therapeutics, Inc.
Stock Option (Right to Buy)
2011-04-19+25,000→ 25,000 total
Conversion
Ocera Therapeutics, Inc.
Common Stock
2011-04-06+78,175→ 2,181,798 total
Conversion
Ocera Therapeutics, Inc.
Series A Convertible Preferred Stock
2011-04-06−547,229→ 0 total
Conversion
Ocera Therapeutics, Inc.
Common Stock
2011-04-06+2,103,623→ 2,103,623 total
Conversion
Ocera Therapeutics, Inc.
Series A Convertible Preferred Stock
2011-04-06−14,725,374→ 0 total
Purchase
Ocera Therapeutics, Inc.
Common Stock
2011-04-06$4.00/sh+14,568→ 2,999,320 total
Conversion
Ocera Therapeutics, Inc.
Series A Convertible Preferred Stock
2011-04-06−55,946→ 0 total
Conversion
Ocera Therapeutics, Inc.
Common Stock
2011-04-06+7,988→ 2,189,786 total
Purchase
Ocera Therapeutics, Inc.
Common Stock
2011-04-06$4.00/sh+2,966→ 3,002,286 total
Purchase
Ocera Therapeutics, Inc.
Common Stock
2011-04-06$4.00/sh+794,966→ 2,984,752 total
Conversion
ZOGENIX, INC.
Series B Convertible Preferred Stock
2010-11-29−51,239→ 0 total
Conversion
ZOGENIX, INC.
Series B Convertible Preferred Stock
2010-11-29−18,406→ 0 total
Conversion
ZOGENIX, INC.
Common Stock
2010-11-29+392,585→ 883,087 total
Purchase
ZOGENIX, INC.
Common Stock
2010-11-29$4.00/sh+5,476→ 14,700 total
Purchase
ZOGENIX, INC.
Common Stock
2010-11-29$4.00/sh+1,967→ 5,280 total
Conversion
ZOGENIX, INC.
8% Convertible Promissory Note
2010-11-29−392,585→ 0 total
Conversion
ZOGENIX, INC.
Common Stock
2010-11-29+42,840→ 42,840 total
Purchase
ZOGENIX, INC.
Common Stock
2010-11-29$4.00/sh+3,178→ 56,094 total
Conversion
ZOGENIX, INC.
8% Convertible Promissory Note
2010-11-29−2,379→ 0 total
Conversion
ZOGENIX, INC.
Common Stock
2010-11-29+1,152,780→ 1,152,780 total
Conversion
ZOGENIX, INC.
Common Stock
2010-11-29+129,855→ 1,489,794 total
Conversion
ZOGENIX, INC.
Series A-1 Convertible Preferred Stock
2010-11-29−43,800→ 0 total
Purchase
ZOGENIX, INC.
Common Stock
2010-11-29$4.00/sh+173,399→ 1,663,193 total
Conversion
ZOGENIX, INC.
Common Stock
2010-11-29+7,697→ 50,537 total
Conversion
ZOGENIX, INC.
Common Stock
2010-11-29+2,379→ 52,916 total
Conversion
ZOGENIX, INC.
Common Stock
2010-11-29+786→ 5,166 total
Purchase
ZOGENIX, INC.
Common Stock
2010-11-29$4.00/sh+647→ 6,297 total
Conversion
ZOGENIX, INC.
Series A-1 Convertible Preferred Stock
2010-11-29−11,527,800→ 0 total
Conversion
ZOGENIX, INC.
Series B Convertible Preferred Stock
2010-11-29−2,071,593→ 0 total
Conversion
ZOGENIX, INC.
8% Convertible Promissory Note
2010-11-29−129,855→ 0 total
Conversion
ZOGENIX, INC.
Series A-1 Convertible Preferred Stock
2010-11-29−428,400→ 0 total
Conversion
ZOGENIX, INC.
8% Convertible Promissory Note
2010-11-29−484→ 0 total
Conversion
ZOGENIX, INC.
Common Stock
2010-11-29+207,159→ 1,359,939 total

Companies

Recent Filings

Address

60 SOUTH 6TH STREET SUITE 3620

MINNEAPOLIS, MN, 55402

View on SEC.gov